For a sterile medicine, the container is part of the product. A vial, ampoule, prefilled syringe or eye drop bottle does far more than hold the drug. It keeps the product sterile until use, protects it from light, oxygen and moisture, must not react with or leach into the formulation, and must allow the healthcare professional or patient to deliver the correct dose safely.
Choosing the right primary packaging is therefore a technical and regulatory decision, not just a commercial one. Kilitch Healthcare helps partners select and qualify primary packaging for sterile injectables and ophthalmic products as part of development, technology transfer and manufacturing projects.
Container | Typical products | Key considerations |
Glass ampoules | Small-volume single-dose injections | Glass quality, breakage, glass particles on opening, sealing integrity |
Glass vials with stoppers | Single- and multi-dose injectables, lyophilised products | Glass type, stopper material, seal integrity, compatibility |
Prefilled syringes | Ready-to-use injectable doses | Barrel material, plunger, siliconisation, needle or luer design |
Multi-dose eye drop bottles | Preserved ophthalmic solutions and suspensions | Plastic type, nozzle drop size, preservative compatibility |
Preservative-free multi-dose bottles | Ophthalmic products without preservatives | Valve or filter design to prevent contamination |
Unit-dose ophthalmic containers | Single-use preservative-free eye drops | Seal integrity, ease of opening, dose volume |
Nasal spray bottles and pumps | Nasal formulations | Spray pattern, dose accuracy, pump compatibility |
Kilitch works with these formats across our sterile injectable, prefilled syringe, ophthalmic and nasal formulation manufacturing.
Pharmaceutical glass is classified by its chemical resistance. Borosilicate glass is commonly used for injectables because of its strong resistance to chemical attack. Some formulations, especially those with high pH or certain buffers, can interact with glass over time, potentially causing delamination or particles. Selecting the right glass type and supplier, and confirming compatibility through stability studies, helps avoid these issues.
Glass vials and ampoules are washed and depyrogenated before filling. Their dimensions must be consistent so they run smoothly on filling and sealing equipment.
Stoppers close vials and are pierced by needles during use. They must:
Stopper material, coatings and supplier qualification are reviewed for each product. Aluminium or flip-off seals secure the stopper and show evidence of tampering.
Prefilled syringes offer convenience and accurate dosing and reduce preparation errors in hospitals. They also bring technical considerations: the barrel material, plunger stopper, lubrication and tip cap can all interact with the product. Break-loose and glide forces must stay within acceptable limits throughout shelf life so the syringe is easy to use. Learn more on our page on prefilled syringe manufacturing.
Eye drop packaging affects both safety and patient experience:
Our ophthalmic formulation development work considers packaging and formulation together, because each affects the other.
Before a container is used commercially, it should be qualified:
This evidence supports regulatory submissions, as described in Module 3 of the CTD dossier, and helps prevent problems after launch.
Regulators expect a description of the container closure system and evidence of its suitability. This typically includes material details, specifications, compatibility data and stability results. Changing a container or supplier after approval may require notifying or seeking approval from regulators, so getting packaging right early saves time later. Kilitch’s technology transfer and formulation development teams consider these requirements from the start.
Beyond the primary container, cartons, leaflets and labels carry critical information and protect products during distribution. Export markets may require specific languages, pack sizes and serialisation. Hospital and tender supplies may need special labelling. Kilitch coordinates secondary packaging with partners according to market requirements. See our page on pharmaceutical export.
Components in contact with a drug can release chemical substances. Extractables are compounds that can be released under aggressive laboratory conditions, while leachables are those that actually migrate into the product under normal storage. For injectables and ophthalmic products, where the product contacts sensitive tissues or enters the bloodstream directly, assessing these substances is especially important. The level of evaluation depends on the route of administration, product composition, contact time and component materials. Supplier data, literature and targeted studies are combined to justify that leachables are within safe limits.
Pharmaceutical brands are increasingly interested in reducing packaging waste. Options can include right-sizing cartons, reducing unnecessary secondary packaging and selecting materials with lower environmental impact. For sterile products, however, any change must not compromise sterility, stability or safety, and may require regulatory review. Kilitch can discuss practical packaging improvements with partners while keeping product protection the first priority.
Packaging components can become bottlenecks. Specialised glass, stoppers, syringes and ophthalmic bottles may have long lead times, limited suppliers or minimum order quantities. A shortage of a single component can stop production even when the drug itself is available. Partners can reduce this risk by qualifying suitable alternative suppliers where possible, maintaining safety stock and sharing forecasts early. Any change of supplier for an approved product should go through change control and regulatory assessment before use.
Should my injectable be in a vial, ampoule or prefilled syringe?
It depends on dose type, stability, market preference, cost and regulatory factors. We assess options with partners during development.
Why does stopper selection matter?
Stoppers can release extractables, affect sterility and influence drying of lyophilised products, so the material must suit the formulation.
What is container closure integrity?
It is the ability of the container and closure to keep the product sterile and protected throughout its shelf life.
Can packaging be changed after approval?
Changes are possible but may require regulatory notification or approval, so careful initial selection is important.
Do you support preservative-free eye drop packaging?
Preservative-free options can be discussed based on product and market needs.
Tell us about your product, intended container and target markets. We will help you select and qualify suitable primary packaging. Contact Kilitch Healthcare or explore our services.